Company DSF Notices
| Company |
BioLineRX |
| Ticker Symbol |
BLRX |
| CUSIP Number |
09071M304 (Active) |
| US ISIN |
US09071M304 |
| Country |
Israel |
| Security Type |
ADR |
| Listing Exchange |
NASDAQ |
| Ratio (ORD:DR) |
600:1 |
Click here to search DSF for other DR programs
Questions may be directed to: Ken Seely 973-461-7029 or Keith Balwan 973-461-7038
For further information on Citi's Depositary Receipt Services, visit
www.citi.com/adr